Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1998-10-19
pubmed:abstractText
Quantitative assays are needed to characterize the multilineage engraftment potential of clinical hematopoietic grafts. After we observed a dose-response relationship between the number of human hematopoietic cells transplanted into nonobese diabetic-scid/scid (NOD/SCID) mice and the number of human CD45+ cells recovered in the chimeras' marrows and spleens, we sought to develop a multiple linear regression model that allows quantitative comparisons of human cell engraftment in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1081-5589
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
303-11
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9737093-Adult, pubmed-meshheading:9737093-Animals, pubmed-meshheading:9737093-Antigens, CD13, pubmed-meshheading:9737093-Antigens, CD19, pubmed-meshheading:9737093-Antigens, CD34, pubmed-meshheading:9737093-B-Lymphocytes, pubmed-meshheading:9737093-Chimera, pubmed-meshheading:9737093-Graft Enhancement, Immunologic, pubmed-meshheading:9737093-Graft Survival, pubmed-meshheading:9737093-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:9737093-Humans, pubmed-meshheading:9737093-Lymphocyte Depletion, pubmed-meshheading:9737093-Mice, pubmed-meshheading:9737093-Mice, Inbred NOD, pubmed-meshheading:9737093-Mice, SCID, pubmed-meshheading:9737093-T-Lymphocytes, pubmed-meshheading:9737093-Transplantation, Heterologous, pubmed-meshheading:9737093-Transplantation Conditioning
pubmed:year
1998
pubmed:articleTitle
In vivo engraftment potential of clinical hematopoietic grafts.
pubmed:affiliation
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-5001, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't